Skip to main content

Nasdaq IPOs

Solid tumor biotech Oncorus prices IPO at $15 midpoint

5 years 11 months ago
Oncorus, a Phase 1 biotech developing oncolytic virus therapies for solid tumors, raised $87 million by offering 5.8 million shares at $15, within the range of $14 to $16. Oncorus plans to list on the Nasdaq under the symbol ONCR. Jefferies, Evercore ISI and Piper Sandler acted a
Renaissance Capital

Charles Ergen's TMT SPAC CONX files for a $1 billion IPO

6 years ago
CONX, a blank check company formed by TMT industry veteran Charles Ergen, filed on Thursday with the SEC to raise up to $1.0 billion in an initial public offering. The Littleton, CO-based company plans to raise $1.0 billion by offering 100 million units at $10. Each uni
Renaissance Capital

Updated: Renaissance Capital's 3Q 2020 US IPO Market Review

6 years ago
IPO Frenzy Drives Busiest Third Quarter Since 2000 The US IPO market had its busiest third quarter by deal count since the Dot-com era, with 81 IPOs raising $28.5 billion. The high volume combined with several large deals resulted in the largest quarter by proceeds in six years.
Renaissance Capital
Checked
6 minutes 5 seconds ago
This feed is responsible for generating the rss feed related to the topic IPOs
Subscribe to Nasdaq IPOs feed